News - Licensing, Rest of the World


Popular Filters

1 to 25 of 27 results

uniQure signs up Medison to distribute Glybera in Israel

uniQure signs up Medison to distribute Glybera in Israel


Netherlands-based human gene therapy firm uniQure has entered an exclusive distribution agreement with…

BiotechnologyGlyberaLicensingMedison PharmaRare diseasesRest of the WorlduniQure

Recordati gains certain rights to Apricus’ Vitaros


Italian drugmaker Recordati has signed an exclusive license agreement with the USA’s Apricus Biosciences…

Apricus BioscienceEastern EuropeLicensingMen's HealthPharmaceuticalRecordatiRest of the WorldTurkeyVitaros

Sanofi to commercialize Vivus ED drug in Africa, Middle East, Turkey and CIS/Russia

Sanofi to commercialize Vivus ED drug in Africa, Middle East, Turkey and CIS/Russia


US drugmaker Vivus has entered into a license and commercialization agreement with French pharma major…

avanafilEastern EuropeLicensingMarkets & MarketingMen's HealthPharmaceuticalRest of the WorldSanofiVivus

CleveXel Pharma and Dynamix to develop oral treatment for RA


CleveXel Pharma has entered into a partnering agreement with venture-backed Israeli biopharmaceutical…

Anti-Arthritics/RheumaticsCleveXel PharmaDynamix PharmaceuticalsEuropeLicensingPharmaceuticalResearchRest of the World

Can-Fite BioPharma to list on NYSE

Can-Fite BioPharma to list on NYSE


Israel-based biotech company Can-Fite BioPharma (TASE: CFBI) has announced that its Level II American…

BiotechnologyCan-Fite BioPharmaLicensingMarkets & MarketingRest of the WorldUSA

Majorelle to market Apricus’ ED product in France, Monaco and certain African countries


USA-based Apricus Biosciences has signed an exclusive license agreement with Laboratoires Majorelle,…

Apricus BioscienceEuropeLaboratoires MajorelleLicensingMen's HealthPharmaceuticalRest of the WorldVitaros

Horizon Pharma and Mundipharma in deal for Lodotra in Middle East and Africa


USA-based Horizon Pharma has signed an exclusive agreement with privately-held Swiss drugmaker Mundipharma…

Anti-Arthritics/RheumaticsHorizon PharmaLicensingLodotraMundipharmaPharmaceuticalRest of the World

Prima BioMed and Neopharm in licensing deal for CVac in Israel


Australia’s Prima BioMed has entered into a binding term sheet granting Israeli firm Neopharm Group…

CVacLicensingNeopharmaOncologyPharmaceuticalPrima BioMedRest of the World

SOBI gains rights to distribute Ravicti in Middle East


Swedish Orphan Biovitrum says Hyperion Therapeutics has granted it exclusive rights to distribute its…

Genito-urinaryHyperion TherapeuticsLicensingPharmaceuticalRavictiRest of the WorldSobiSwedish Orphan Biovitrum

Cardiome in deal for commercialization of Brinavess in Israel


Canada-based Cardiome Pharma (TSX: COM) has entered into an agreement with Tzamal Medical to sell and…

BrinavessCardio-vascularCardiome PharmaLicensingPharmaceuticalRest of the WorldTzamal Medical

BMG Pharma and Julphar in women's health licensing deal


Italian specialty drugmaker BMG Pharma and United Arab Emirates-based Julphar - Gulf Pharmaceutical Industries…

BMG GinoxilBMG PharmaJulpharLicensingPharmaceuticalRest of the WorldWomen's Health

Auxilium and SOBI collaborate on Xiapex


USA-based Auxilium Pharmaceuticals (Nasdaq: AUXL) and Swedish Orphan Biovitrum (STO: SOBI) have entered…

Auxilium PharmaceuticalsEuropeLicensingPharmaceuticalRare diseasesRest of the WorldSwedish Orphan BiovitrumXiapex

Hikma licenses Vibativ from Theravance for MENA region


Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) says it has signed an exclusive commercialization…

Antibiotics and Infectious diseasesHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldTheravanceVibativ

Meda expands collaboration with India's Cipla on Dymista


Swedish drugmaker Meda (OMX: MEDA A) is broadening its collaboration with Indian pharmaceutical company…

Asia-PacificCiplaDymistaLicensingMedaPharmaceuticalRespiratory and PulmonaryRest of the WorldSouth America

Hikma in-licenses inhaled insulin for MENA; Advaxis and FusionVax Asia deal


Jordan-based Hikma Pharmaceuticals (LSE: HIK) has signed a licensing and distribution agreement with…

AdvaxisADXS-HPVAsia-PacificDance 01Dance BiopharmDiabetesFusionVaxHikma PharmaceuticalsImmunologicalsLicensingOncologyPharmaceuticalRest of the World

Galena Biopharma leaps on deal with Teva for NeuVax in Israel


Shares of US biotech firm Galena Biopharma (Nasdaq: GALE) leapt 13.7% to $2.32 in pre-market trading…

BiotechnologyGalena BioPharmaLicensingnelipepimut-SNeuVaxOncologyRest of the WorldTeva Pharmaceutical IndustriesVaccines

Hikma signs deal with GP Pharma for Lutrate 1 month in MENA region


Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) has signed a license and supply agreement for the…

GenericsGP PharmHikma PharmaceuticalsLicensingLutrateOncologyRest of the World

Merck & Co in-licenses Chimerix antiviral; Fiocruz to make ARVs in Africa


USA-based Chimerix, a venture-funded biotech focused on developing novel oral antivirals, has announced…

Anti-viralsChimerixCMX001CMX157FiocruzGlobalLicensingMarkets & MarketingMerck & CoPharmaceuticalRest of the World

Teva gets rights to BioAlliance's Sitavig in Israel


French drugmaker BioAlliance Pharma (Euronext Paris: BIO) has signed an exclusive license agreement for…

Anti-viralsBioAlliance PharmaLicensingPharmaceuticalRest of the WorldSitavigTeva Pharmaceutical Industries

Fero expands diabetes treatment Sucanon presence in the Middle East


Canada-based Fero Industries (OTCQB: FROI), the exclusive owner, producer and distributor of the type…

DiabetesFero IndustriesLicensingPharmaceuticalPremium PharmaRest of the WorldSucanon

AEterna Zentaris signs up Hikma to commercialize perifosine in MENA region


Canada’s AEterna Zentaris (TSX: AEZ) has signed an exclusive commercialization and licensing agreement…

AEterna ZentarisGenericsHikma PharmaceuticalsLicensingOncologyperifosinePharmaceuticalRest of the World

Natco in biogenerics in deal with Mabxience; plans generic launches in South Africa


Hyderabad, India-based generic drugmaker Natco Pharma (524816: BY) has entered into an exclusive agreement…

Asia-PacificbevacizumabBiotechnologyetanerceptGenericsLicensingMabxienceMarkets & MarketingNatco PharmaRest of the Worldrituximabtrastuzumab

Second Indian generics deal for SA’s Litha, this one with Micro Labs


In a second deal with an Indian drugmaker, South Africa’s Litha Healthcare has signed an exclusive…

Asia-PacificGenericsLicensingLitha HealthcareRest of the World

1 to 25 of 27 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top